y 27632 has been researched along with Graft-Versus-Host Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghobrial, RM; Kloc, M; Subuddhi, A; Ubelaker, HV; Uosef, A; Zou, D | 1 |
1 other study(ies) available for y 27632 and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Comparative transcriptome profile of mouse macrophages treated with the RhoA/Rock pathway inhibitors Y27632, Fingolimod (Gilenya), and Rezurock (Belumosudil, SLx-2119).
Topics: Actins; Animals; Fibrosis; Fingolimod Hydrochloride; Graft vs Host Disease; Humans; Macrophages; Mice; rho-Associated Kinases; rhoA GTP-Binding Protein; Transcriptome | 2023 |